购物车
- 全部删除
- 您的购物车当前为空
VU590 是一种具有高效性和中等选择性的肾外髓质钾 ROMK (Kir1.1) 抑制剂。VU590 抑制 Kir7.1,可调节子宫肌层收缩力和黑皮质素信号传导。
VU590 是一种具有高效性和中等选择性的肾外髓质钾 ROMK (Kir1.1) 抑制剂。VU590 抑制 Kir7.1,可调节子宫肌层收缩力和黑皮质素信号传导。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 266 | 现货 | |
5 mg | ¥ 619 | 现货 | |
10 mg | ¥ 993 | 现货 | |
25 mg | ¥ 1,650 | 现货 | |
50 mg | ¥ 2,480 | 现货 | |
100 mg | ¥ 3,730 | 现货 | |
500 mg | ¥ 7,850 | 现货 |
产品描述 | VU590 is a potent and moderately selective inhibitor of extrarenal medullary potassium ROMK (Kir1.1).VU590 inhibits Kir7.1 and modulates uterine myometrial contractility and melanocortin signalling. |
靶点活性 | Kir1.1:290 nM, Kir7.1:8 μM |
分子量 | 488.53 |
分子式 | C24H32N4O7 |
CAS No. | 313505-85-0 |
Smiles | Cl.Cl.[O-][N+](=O)c1ccc(CN2CCOCCOCCN(Cc3ccc(cc3)[N+]([O-])=O)CCOCC2)cc1 |
密度 | 1.216 g/cm3 (Predicted) |
存储 | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||
溶解度信息 | DMSO: < 20 mg/mL, Sonication is recommended. H2O: 1 mg/mL (2.05 mM), Sonication is recommended. | ||||||||||
溶液配制表 | |||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容